Frequentist Approaches to Interim Monitoring of Clinical Trials: A Review of Recent Theoretical Developments
暂无分享,去创建一个
[1] A. Gould,et al. Sample size re-estimation without unblinding for normally distributed outcomes with unknown variance , 1992 .
[2] J. Berger. Statistical Decision Theory and Bayesian Analysis , 1988 .
[3] J. Peto,et al. Asymptotically Efficient Rank Invariant Test Procedures , 1972 .
[4] Scott S. Emerson,et al. Statistical Packages for Group Sequential Methods , 1996 .
[5] S J Pocock,et al. Interim analyses for randomized clinical trials: the group sequential approach. , 1982, Biometrics.
[6] Herman Chernoff,et al. Sequential medical trials involving paired data , 1981 .
[7] Nancy L. Geller,et al. Design of Group Sequential Clinical Trials with Multiple Endpoints , 1989 .
[8] A. Gould. Planning and revising the sample size for a trial. , 1995, Statistics in Medicine.
[9] Anastasios A. Tsiatis,et al. Repeated Significance Testing for a General Class of Statistics Used in Censored Survival Analysis , 1982 .
[10] I. Bross,et al. Sequential Medical Plans. , 1952 .
[11] David L. DeMets,et al. An overview of sequential methods and their application in clinical trials , 1984 .
[12] R J Cook,et al. Guidelines for monitoring efficacy and toxicity responses in clinical trials. , 1994, Biometrics.
[13] James H. Ware,et al. On distribution-free tests for equality of survival distributions , 1977 .
[14] N L Geller,et al. On the choice of times for data analysis in group sequential clinical trials. , 1991, Biometrics.
[15] D. Zucker,et al. Sequential monitoring of clinical trials: the role of information and Brownian motion. , 1993, Statistics in medicine.
[16] D J Spiegelhalter,et al. Comparison of Bayesian with group sequential methods for monitoring clinical trials. , 1989, Controlled clinical trials.
[17] Anastasios A. Tsiatis,et al. Repeated significance testing in longitudinal clinical trials , 1996 .
[18] D L DeMets,et al. The alpha spending function approach to interim data analyses. , 1995, Cancer treatment and research.
[19] J. Whitehead. Overrunning and underrunning in sequential clinical trials. , 1992, Controlled Clinical Trials.
[20] D J Spiegelhalter,et al. The CHART trials: Bayesian design and monitoring in practice. CHART Steering Committee. , 1994, Statistics in medicine.
[21] M D Hughes,et al. Practical problems in interim analyses, with particular regard to estimation. , 1989, Controlled clinical trials.
[22] R. Madsen,et al. P values for tests using a repeated significance test design , 1982 .
[23] S. Pocock. Group sequential methods in the design and analysis of clinical trials , 1977 .
[24] Thomas Sellke,et al. Sequential analysis of the proportional hazards model , 1983 .
[25] B P Carlin,et al. Robust Bayesian approaches for clinical trial monitoring. , 1996, Statistics in medicine.
[26] D A Berry,et al. Decision making during a phase III randomized controlled trial. , 1994, Controlled clinical trials.
[27] Christopher Jennison,et al. Efficient group sequential tests with unpredictable group sizes , 1987 .
[28] D. Spiegelhalter,et al. The Assessment of the Subjective Opinion and its Use in Relation to Stopping Rules for Clinical Trials , 1983 .
[29] D I Tang,et al. On the design and analysis of randomized clinical trials with multiple endpoints. , 1993, Biometrics.
[30] Donald B. Rubin,et al. Sensitivity of Bayes Inference with Data-Dependent Stopping Rules , 1984 .
[31] Sung C. Choi,et al. Early decision in clinical trials when the treatment differences are small. Experience of a controlled trial in head trauma. , 1985, Controlled clinical trials.
[32] S S Emerson. Computation of the uniform minimum variance unbiased estimator of a normal mean following a group sequential trial. , 1993, Computers and biomedical research, an international journal.
[33] J. Kalbfleisch,et al. The Statistical Analysis of Failure Time Data , 1980 .
[34] K K Lan,et al. Monitoring boundaries for adverse effects in long-term clinical trials. , 1986, Controlled clinical trials.
[35] P K Andersen,et al. Conditional power calculations as an aid in the decision whether to continue a clinical trial. , 1987, Controlled clinical trials.
[36] J M Lachin,et al. Sequential monitoring of survival data with the Wilcoxon statistic. , 1995, Biometrics.
[37] N L Geller,et al. The analysis of multiple endpoints in clinical trials. , 1987, Biometrics.
[38] Max Halperin,et al. More flexible sequential and non-sequential designs in long-term clinical trial , 1984 .
[39] P. Thall,et al. Bayesian sequential monitoring designs for single-arm clinical trials with multiple outcomes. , 1995, Statistics in medicine.
[40] K. Bailey,et al. Estimation and comparison of changes in the presence of informative right censoring: conditional linear model. , 1989, Biometrics.
[41] D. Heitjan,et al. Bayesian interim analysis of phase II cancer clinical trials. , 1997, Statistics in medicine.
[42] D J Spiegelhalter,et al. Application of Bayesian statistics to decision making during a clinical trial. , 1992, Statistics in medicine.
[43] D A Follmann,et al. Monitoring pairwise comparisons in multi-armed clinical trials. , 1994, Biometrics.
[44] David L. DeMets,et al. Sequential Rank Tests with Repeated Measurements in Clinical Trials , 1992 .
[45] D A Follmann,et al. Monitoring multi-armed trials. , 1994, Statistics in medicine.
[46] David L. DeMets,et al. Group sequential methods for clinical trials with a one-sided hypothesis , 1980 .
[47] J B Kadane,et al. Progress toward a more ethical method for clinical trials. , 1986, The Journal of medicine and philosophy.
[48] T. Lai. Optimal Stopping and Sequential Tests which Minimize the Maximum Expected Sample Size , 1973 .
[49] John M. Lachin,et al. Interim analyses with repeated measurements in a sequential clinical trial , 1990 .
[50] T R Fleming,et al. Symmetric group sequential test designs. , 1989, Biometrics.
[51] J Whitehead,et al. Sequential methods based on the boundaries approach for the clinical comparison of survival times. , 1994, Statistics in medicine.
[52] Anastasios A. Tsiatis,et al. Group sequential tests with censored survival data adjusting for covariates , 1985 .
[53] Christopher Jennison,et al. Exact calculations for sequential t, X2 and F tests , 1991 .
[54] A L Gould,et al. Interim analyses for monitoring clinical trials that do not materially affect the type I error rate. , 1992, Statistics in medicine.
[55] A. Tsiatis,et al. Approximately optimal one-parameter boundaries for group sequential trials. , 1987, Biometrics.
[56] L. M. Berliner,et al. Robust Bayes and Empirical Bayes Analysis with $_\epsilon$-Contaminated Priors , 1986 .
[57] K. K. Lan,et al. Discrete sequential boundaries for clinical trials , 1983 .
[58] D L DeMets,et al. Interim analysis: the alpha spending function approach. , 1994, Statistics in medicine.
[59] J. W. Lee,et al. Group sequential testing in clinical trials with multivariate observations: a review. , 1994, Statistics in medicine.
[60] P. O'Brien,et al. A multiple testing procedure for clinical trials. , 1979, Biometrics.
[61] K Kim,et al. Sample size determination for group sequential clinical trials with immediate response. , 1992, Statistics in medicine.
[62] K. K. Lan,et al. Stochastically curtailed tests in long–term clinical trials , 1982 .
[63] Christopher Jennison,et al. Interim analyses: the repeated confidence interval approach , 1989 .
[64] Anastasios A. Tsiatis,et al. Exact confidence intervals following a group sequential trial: A comparison of methods , 1988 .
[65] David M. Reboussin,et al. Information and information fractions for design and sequential monitoring of clinical trials , 1994 .
[66] K Kim. Study duration for group sequential clinical trials with censored survival data adjusting for stratification. , 1992, Statistics in medicine.
[67] Choi Sc,et al. Monitoring clinical trials based on predictive probability of significance. , 1989 .
[68] J. Bernardo. Reference Posterior Distributions for Bayesian Inference , 1979 .
[69] D A Berry,et al. One-sided sequential stopping boundaries for clinical trials: a decision-theoretic approach. , 1988, Biometrics.
[70] L Wasserman,et al. Robust Bayesian methods for monitoring clinical trials. , 1995, Statistics in medicine.
[71] Anastasios A. Tsiatis,et al. Group sequential designs for one-sided and two-sided hypothesis testing with provision for early stopping in favor of the null hypothesis , 1994 .
[72] J M Lachin,et al. Group sequential distribution-free methods for the analysis of multivariate observations. , 1992, Biometrics.
[73] D O Scharfstein,et al. The use of simulation and bootstrap in information-based group sequential studies. , 1998, Statistics in medicine.
[74] David L. DeMets,et al. Design and analysis of group sequential tests based on the type I error spending rate function , 1987 .
[75] Michael Woodroofe,et al. Estimation after sequential testing: A simple approach for a truncated sequential probability ratio test , 1992 .
[76] M D Hughes,et al. Stopping guidelines for clinical trials with multiple treatments. , 1993, Statistics in medicine.
[77] K Kim,et al. Study duration for clinical trials with survival response and early stopping rule. , 1990, Biometrics.
[78] D L DeMets,et al. Changing frequency of interim analysis in sequential monitoring. , 1989, Biometrics.
[79] Anastasios A. Tsiatis,et al. The asymptotic joint distribution of the efficient scores test for the proportional hazards model calculated over time , 1981 .
[80] Christopher Jennison,et al. Statistical Approaches to Interim Monitoring of Medical Trials: A Review and Commentary , 1990 .
[81] Eric V. Slud,et al. Two-Sample Repeated Significance Tests Based on the Modified Wilcoxon Statistic , 1982 .
[82] M C Wu,et al. Sequential monitoring for comparison of changes in a response variable in clinical studies. , 1992, Biometrics.
[83] Lee-Jen Wei,et al. Combining dependent tests with incomplete repeated measurements , 1985 .
[84] P M Fayers,et al. Tutorial in biostatistics Bayesian data monitoring in clinical trials. , 1997, Statistics in medicine.
[85] K K Lan,et al. The B-value: a tool for monitoring data. , 1988, Biometrics.
[86] D. Berry,et al. Interim analyses in clinical trials: classical vs. Bayesian approaches. , 1985, Statistics in medicine.
[87] P. O'Brien,et al. Confidence intervals following group sequential tests. , 1986, Controlled clinical trials.
[88] David L. DeMets,et al. Asymmetric group sequential boundaries for monitoring clinical trials , 1982 .
[89] John Whitehead,et al. On the bias of maximum likelihood estimation following a sequential test , 1986 .
[90] Susan Todd,et al. Point and interval estimation following a sequential clinical trial , 1996 .
[91] W J Shih,et al. Design for sample size re-estimation with interim data for double-blind clinical trials with binary outcomes. , 1997, Statistics in medicine.
[92] S G Hilsenbeck. Early termination of a phase II clinical trial. , 1988, Controlled clinical trials.
[93] N Stallard,et al. Comparison of the spending function method and the Christmas tree correction for group sequential trials. , 1996, Journal of biopharmaceutical statistics.
[94] David L. DeMets,et al. Sequential Comparison of Changes with Repeated Measurements Data , 1991 .
[95] J. Whitehead,et al. A FORTRAN program for the design and analysis of sequential clinical trials. , 1983, Computers and biomedical research, an international journal.
[96] D. Siegmund. Corrected diffusion approximations in certain random walk problems , 1979, Advances in Applied Probability.
[97] J. Ware,et al. Random-effects models for longitudinal data. , 1982, Biometrics.
[98] Eric V. Slud,et al. Sequential Linear Rank Tests for Two-Sample Censored Survival Data , 1984 .
[99] D. Spiegelhalter,et al. A predictive approach to selecting the size of a clinical trial, based on subjective clinical opinion. , 1986, Statistics in medicine.
[100] Christopher Jennison,et al. Group Sequential Analysis Incorporating Covariate Information , 1997 .
[101] D. Berry. Monitoring accumulating data in a clinical trial. , 1989, Biometrics.
[102] Kung-Jong Lui. A simple generalization of the O'Brien and Fleming group sequential test procedure to more than two treatment groups , 1993 .
[103] D A Berry. Decision analysis and Bayesian methods in clinical trials. , 1995, Cancer treatment and research.
[104] K Kim,et al. Design and analysis of group sequential logrank tests in maximum duration versus information trials. , 1995, Biometrics.
[105] G L Rosner,et al. A Bayesian group sequential design for a multiple arm randomized clinical trial. , 1995, Statistics in medicine.
[106] David L. DeMets,et al. Sequential monitoring of clinical trials with correlated responses , 1996 .
[107] K Kim,et al. Confidence intervals following group sequential tests in clinical trials. , 1987, Biometrics.
[108] David L. DeMets,et al. Stopping guidelines vs stopping rules: a practitioner's point of view , 1984 .
[109] D J Spiegelhalter,et al. Applying Bayesian ideas in drug development and clinical trials. , 1993, Statistics in medicine.
[110] E. Gehan. A GENERALIZED WILCOXON TEST FOR COMPARING ARBITRARILY SINGLY-CENSORED SAMPLES. , 1965, Biometrika.
[111] J. Wolfowitz,et al. Optimum Character of the Sequential Probability Ratio Test , 1948 .
[112] T. Fleming,et al. Parameter estimation following group sequential hypothesis testing , 1990 .
[113] D L Demets,et al. Group sequential procedures: calendar versus information time. , 1989, Statistics in medicine.
[114] S S Emerson,et al. A computationally simpler algorithm for the UMVUE of a normal mean following a group sequential trial. , 1997, Biometrics.
[115] J. S. D. Cani,et al. Group sequential designs using a family of type I error probability spending functions. , 1990, Statistics in medicine.
[116] P. O'Brien. Procedures for comparing samples with multiple endpoints. , 1984, Biometrics.
[117] A A Tsiatis,et al. Exact confidence intervals following a group sequential test. , 1984, Biometrics.
[118] T R Fleming,et al. Designs for group sequential tests. , 1984, Controlled clinical trials.
[119] J M Lachin,et al. Termination of a clinical trial with no treatment group difference: the Lupus Nephritis Collaborative Study. , 1992, Controlled clinical trials.
[120] Michael A. Proschan,et al. Effects of assumption violations on type I error rate in group sequential monitoring , 1992 .
[121] S. Pocock,et al. Stopping rules and estimation problems in clinical trials. , 1988, Statistics in medicine.
[122] A Fletcher,et al. Implications for trials in progress of publication of positive results , 1993, The Lancet.
[123] M. Schervish. Multivariate normal probabilities with error bound , 1984 .
[124] M H Gail,et al. Use of logrank tests and group sequential methods at fixed calendar times. , 1985, Biometrics.
[125] S. Snapinn,et al. Monitoring clinical trials with a conditional probability stopping rule. , 1992, Statistics in medicine.
[126] P. Armitage,et al. Sequential methods in clinical trials. , 1958, American journal of public health and the nation's health.
[127] B W Turnbull,et al. Group sequential tests for bivariate response: interim analyses of clinical trials with both efficacy and safety endpoints. , 1993, Biometrics.
[128] S. Zeger,et al. Longitudinal data analysis using generalized linear models , 1986 .
[129] James M. Robins,et al. Semiparametric Efficiency and its Implication on the Design and Analysis of Group-Sequential Studies , 1997 .
[130] N. Cressie,et al. A sample-size-optimal Bayesian procedure for sequential pharmaceutical trials. , 1994, Biometrics.
[131] T. Fearn,et al. Bayesian statistics : principles, models, and applications , 1990 .
[132] J M Lachin,et al. Implementation of group sequential logrank tests in a maximum duration trial. , 1990, Biometrics.
[133] D. Siegmund. Estimation following sequential tests , 1978 .
[134] D. Schoenfeld. The asymptotic properties of nonparametric tests for comparing survival distributions , 1981 .
[135] P. Diggle,et al. Analysis of Longitudinal Data , 2003 .
[136] D. Siegmund. Sequential Analysis: Tests and Confidence Intervals , 1985 .
[137] R A Betensky,et al. Sequential analysis of censored survival data from three treatment groups. , 1997, Biometrics.
[138] David J. Spiegelhalter,et al. Bayesian Approaches to Randomized Trials , 1994, Bayesian Biostatistics.
[139] R Simon,et al. A decade of progress in statistical methodology for clinical trials. , 1991, Statistics in medicine.
[140] D J Spiegelhalter,et al. A unified method for monitoring and analysing controlled trials. , 1994, Statistics in medicine.
[141] P. Armitage,et al. Repeated Significance Tests on Accumulating Data , 1969 .
[142] P Gustafson,et al. Robustness considerations in Bayesian analysis , 1996, Statistical methods in medical research.
[143] D J Spiegelhalter,et al. The what, why and how of Bayesian clinical trials monitoring. , 1994, Statistics in medicine.
[144] R. Prentice. Linear rank tests with right censored data , 1978 .
[145] M. Chang,et al. Confidence intervals for a normal mean following a group sequential test. , 1989, Biometrics.